|
Hyundai Pharmaceutical Company Limited - Comparative Business Analysis Snapshot
Business Description
Hyundai Pharmaceutical Company Limited. The Company's principal activity is manufacturing of pharmaceuticals and healthcare foods and drinks. Its main medical products include Tenormin tablets, for hypertension and angina pectoris; Zestril tablets, for hypertension and congest heart failure; Elroton tablets, for coronary artery diseases; Surfolase capsules, for acute or chronic respiratory diseases resulting from respiratory obstruction and disturbance in mucous secretion; Norlevo tablets, for oral emergency contraceptives, and Divina tablets, for vasomotor symptoms associated with the menopause menorrhea. The Company also produces healthcare foods for joints and cartilage, and different kinds of healthcare drinks that are made from soybeans, red ginsengs, green teas, pumpkins and others.
Competitor Analysis
This analysis compares Hyundai Pharmaceutical Company Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
